Anti-coagulation effect of Fc fragment against anti-β2-GP1 antibodies in mouse models with APS

International Immunopharmacology

Volumn 11, Issue 1, 2011, Pages 136-140

  Xie, Weidong ^a   Zhang, Yaou ^a   Bu, Cunya ^a   Sun, Shijing ^a   Hu, Shaoliang ^a   Cai, Guoping ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Anti 2 GP1 antibody; Antiphospholipid syndrome; Blood coagulation; Fc fragments; Intravenous immunoglobulin

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; HUMAN; MORTALITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; THROMBOSIS;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS;

EID: 78651427223     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.10.018     Document Type: Article

References (22)

1. C. Agar, G.M. van Os, M. Mörgelin, R.R. Sprenger, J.A. Marquart, and R.T. Urbanus Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome Blood 116 2010 1336 1343
2. J.C. Meijers, P.G. de Groot, and I. Schousboe Beta 2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway Blood 66 1985 1086 1091
3. J. Nimpf, E.M. Bevers, P.H. Bomans, U. Till, H. Wurm, and G.M. Kostner Prothrombinase activity of human platelets is inhibited by beta2-glycoprotein I Biochim Biophys Acta 884 1986 142 149
4. C. Bu, L. Gao, W. Xie, J. Zhang, Y. He, and G. Cai Beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation Arthritis Rheum 60 2009 559 568
5. C. Zoghlami-Rintelen, R. Vormittag, T. Sailer, S. Lehr, P. Quehenberger, and H. Rumpold The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant J Thromb Haemost 3 2005 1160 1165
6. Y. Sherer, Y. Levy, and Y. Shoenfeld Intravenous immunoglobulin therapy of antiphospholipid syndrome Rheumatol Oxf 39 2000 421 426
7. H.M. Gürcan, and A.R. Ahmed Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders Ann Pharmacother 41 2007 812 823
8. E. Konova Intravenous immunoglobulin therapy in antiphospholipid syndrome Clin Rev Allergy Immunol 29 2005 229 236
9. E. Zanon, P. Prandoni, F. Vianello, G. Saggiorato, G. Carraro, and P. Bagatella Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism Thromb Res 96 1999 269 274
10. G.R. Hsiao, R.E. Wolf, and D.L. Kimpel Intravenous immunoglobulin to prevent recurrent thrombosis in the antiphospholipid syndrome J Clin Rheumatol 7 2001 336 339
11. H.M. Gürcan, S. Jeph, Ahmed A.R., G.R. Hsiao, R.E. Wolf, and D.L. Kimpel Intravenous immunoglobulin to prevent recurrent thrombosis in the antiphospholipid syndrome J Clin Rheumatol 7 2001 336 339
12. M.J. Feige, S. Nath, S.R. Catharino, D. Weinfurtner, S. Steinbacher, and J. Buchner Structure of the murine unglycosylated IgG1 Fc fragment J Mol Biol 391 2009 599 608
13. G.P. Cai, Y. Guo, and J.X. Shi Purification of apoliporptein H by polyethylene glycol precipitation Protein Expres Purif 8 1996 341 346
14. I. Marai, B. Gilburd, M. Blank, and Y. Shoenfeld Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome Hum Antibodies 12 2003 57 62
15. M.E. Martinuzzo, R.R. Forastiero, and L.O. Carreras Anti β2 glycoprotein I antibodies: detection and association with thrombosis Br J Haematol 89 397-420 1995 12 15
16. S.S. Pierangeli, R. Espinola, X. Liu, E.N. Harris, and J.E. Salmon Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype Arthritis Rheum 44 2001 876 883
17. V. De Vooght, J.A. Vanoirbeek, K. Luyts, S. Haenen, B. Nemery, and P.H. Hoet Choice of mouse strain influences the outcome in a mouse model of chemical-induced asthma PLoS ONE 5 2010 e12581
18. M. Karakantza, G.L. Theodorou, N. Meimaris, A. Mouzaki, E. John, and A.P. Andonopoulos Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in primary antiphospholipid syndrome Ann Hematol 83 2004 704 711
19. S.S. Pierangeli, and E.N. Harris In vivo models of thrombosis for the antiphospholipid syndrome Lupus 5 1996 451 455
20. R.S. Geha, and F.S. Rosen Intravenous immunoglobulin therapy K.F. Austen, S.J. Burakoff, F.S. Rosen, T.B. Strom, Therapeutic Immunology 1996 Blackwell Science Cambridge (MA) 280 296
21. R.P. Junghans, and C.L. Anderson The protection receptor for IgG catabolism is the b2microglobulin-containing neonatal intestinal transport receptor Proc Natl Acad Sci USA 93 1996 5512 5516
22. M.C. Karlsson, S. Wernersson, T. Diaz de Ståhl, S. Gustavsson, and B. Heyman IgG-mediated suppression of primary antibody responses in Fcg receptor-deficient mice Proc Natl Acad Sci USA 96 1999 2244 2249